|
Protein and method | Function | Site of expression | Relation to PCOS | Population size | Reference |
|
HSP27/2D gel electrophoresis and mass spectrometry | Steroidogenesis, chaperoning and protection against apoptosis | Ovarian tissue | Decreased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
HSP10/2D gel electrophoresis and mass spectrometry | Protect against apoptosis and play a role in follicular atresia | Ovarian tissue | Decreased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
HSP47/2D gel electrophoresis and mass spectrometry | Collagen specific molecular chaperone involved in fibrolytic disease | Ovarian tissue | Increased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
FUSE binding protein 1/2D gel electrophoresis and mass spectrometry | Regulation of insulin function | Ovarian tissue | Increased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
Glyoxylate reductase/ Hydroxypyruvate reductase/2D gel electrophoresis and mass spectrometry | Regulation of insulin function | Ovarian tissue | Increased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
Antithrombin III/2D gel electrophoresis and mass spectrometry | Regulation of fibrinolysis and thrombosis | Ovarian tissue | Decreased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
Annexin A2/2D gel electrophoresis and mass spectrometry | Regulation of fibrinolysis and thrombosis | Ovarian tissue | Decreased | 3 normal women and 3 with PCOS | [13] |
|
Fibrinogen alpha and gamma chain/2D gel electrophoresis and mass spectrometry | Fibrinolysis and blood clotting | Ovarian tissue | Increased | 3 normal women and 3 with PCOS all younger than 30 years old with PCOS | [13] |
|
Laminin A/C/2D gel electrophoresis and mass spectrometry | Regulators of the ovary | Ovarian tissue | Increased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
Vimentin/2D gel electrophoresis and mass spectrometry | Regulator of the ovary | Ovarian tissue | Increased | 3 normal women and 3 with PCOS all younger than 30 years old | [13] |
|
Vitamin D binding protein (DBP)/2D gel electrophoresis and MALDI-TOF | Binding vitamin D | Follicular fluid | Decreased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
Plasma retinol binding protein (RBP4)/2D gel electrophoresis and MALDI-TOF | Binding of retinol | Follicular fluid | Increased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
Transthyretin (TTR)/2D gel electrophoresis and MALDI-TOF | Insulin resistance and obesity | Follicular fluid | Increased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
Apolipoprotein A1/2D gel electrophoresis and MALDI-TOF | Regulate lipid metabolism and has a function in anti-inflammatory pathways | Follicular fluid | Increased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
Apolipoprotein A4/2D gel electrophoresis and MALDI-TOF | Weakest lipophilic capacity and associated with lipid metabolism | Follicular fluid | Increased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
Transferrin/2D gel electrophoresis and MALDI-TOF | Binds iron and transports it. Promote cell growth and development | Follicular fluid | Increased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
DRAM2/2D gel electrophoresis and MALDI-TOF | Apoptosis | Follicular fluid | Decreased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
MAK (Male germ-associated kinase)/2D gel electrophoresis and MALDI-TOF | Plays a role in meiosis of cells | Follicular fluid | Decreased | 30 normal women undergoing IVF and 30 with PCOS | [14] |
|
Glutathione S-transferase M3 (GSTM3)/2D gel electrophoresis and MALDI-MS | Antioxidant involved in breakdown of cytotoxic material | Omental adipose tissue | Increased | 19 obese women undergoing bariatric surgery; 10 with PCOS and 9 nonsymptomatic used as control | [6] |
|
Annexin V/2D gel electrophoresis and MALDI-MS | Phospholipid binding | Omental adipose tissue | Increased | 19 obese women undergoing bariatric surgery; 10 with PCOS and 9 nonsymptomatic used as control | [6] |
|
Peroxiredoxin 2/2D gel electrophoresis and MALDI-MS | Antioxidant | Omental adipose tissue | Decreased | 19 obese women undergoing bariatric surgery; 10 with PCOS and 9 nonsymptomatic used as control | [6] |
|
Actin/2D gel electrophoresis and MALDI-MS | Cytoskeletal protein and gene expression regulation | Omental adipose tissue | Decreased | 19 obese women undergoing bariatric surgery; 10 with PCOS and 9 nonsymptomatic used as control | [6] |
|
TPI1/2D gel electrophoresis and MALDI-MS | interconversion of dihydroxyacetone phosphate and glyceraldehydes-3-phosphate in preparation for glycolysis | Omental adipose tissue | Decreased | 19 obese women undergoing bariatric surgery; 10 with PCOS and 9 nonsymptomatic used as control | [6] |
|
Prolidase | Matrix metalloproteinase | Serum | Increased | 30 PCOS patients and 28 normal women | [37] |
|